The STRIDES study will evaluate the safety and efficacy of SLS-005 (Trehalose Injection, 90.5 mg/mL for Intravenous Infusion) for the Treatment of Adults with Spinocerebellar Ataxia.
For SLS-005 Trehalose clinical study queries, please contact [email protected].
For additional information, please reach out to the recruitment contacts provided on clinicaltrials.gov Identifier: NCT05490563